---
title: "Immune Design from Molecule to Organoid Interactive Lab | Sandbox Physics"
description: "Change one receptor, then watch that decision cross a cell and rewrite a tissue. How can one molecular recognition event cross a cell threshold and become tissue-wide clearance?"
canonical_url: "https://sandboxphysics.com/labs/multiscale-immune-surveillance/"
language: "en"
page_type: "lab"
alternate_languages:
  zh-CN: "https://sandboxphysics.com/zh/labs/multiscale-immune-surveillance/"
---

Multiscale biophysics · immune engineering

# Immune Design · Molecule to Organoid

One 3D observatory opens three scales at once: receptor–antigen binding on the left, a T cell compressing graded input into a switch-like decision in the center, and effector cells infiltrating and clearing a tumor organoid on the right. Tune the system and expose its real bottleneck.

> Interactive simulation: open this page in a web browser to change the parameters and run the model.

This is an educational causal model: binding uses effective surface units, the cell uses a cooperative threshold, and tissue outcome uses a mean clearance rate. It explains why failure at one scale defeats upstream optimization; it does not predict patient response or dose.

Physics tutorial

## How does one molecule reach a whole tissue?

**Background** Immune engineering is not three independent problems. A receptor first contacts a target molecule; intracellular networks compress that graded input into an activated or silent decision; only activated effectors that enter tissue and perform serial killing can produce macroscopic clearance.

**Why it matters** This is why making a receptor “stickier” does not guarantee success. Scarce antigen, a strong checkpoint brake, or poor tissue access can each reduce the whole cascade to zero.

Start with the essentials

- **Focus question**: Which scale limits final clearance, and when does improving an upstream molecular design matter—or disappear inside a downstream bottleneck?
- **One-sentence intuition**: Multiscale design optimizes the complete causal product, not an isolated maximum. Molecular occupancy creates the input, a cooperative threshold converts it into a cell decision, and tissue access sets the final clearance rate.

### Core mathematical model

#### Molecular binding gate

$$
\theta=\frac{\rho_A}{\rho_A+K_D^\ast}
$$

Effective surface units represent antigen presentation and half-saturation. More antigen or a lower effective half-saturation raises occupancy. This is an educational mapping, not a claim that membrane binding is a bulk concentration.

#### Cooperative cell threshold

$$
A=\frac{\left[(1-b)\theta\right]^n}{\left[(1-b)\theta\right]^n+\tau^n}
$$

The checkpoint brake $b$ first attenuates the input; cooperativity $n$ then compresses a smooth molecular change into a steep, almost digital cellular decision.

#### Tissue clearance

$$
C(t)=1-\exp\!\left[-k_{\max}A\,\frac{R_{E:T}}{R_{E:T}+R_{1/2}}\,t\right]
$$

The organoid layer multiplies activation by effector access to obtain a mean clearance rate. Real tissue also includes migration, exhaustion, spatial barriers, and clonal heterogeneity; this equation keeps only the key serial-system structure.

### Common difficulties

#### Higher affinity is not the same as better therapy

**Typical misconception** If receptor binding becomes strong enough, the tissue must be cleared.

**Better mental model** Binding opens only the first gate. Checkpoints, signaling thresholds, infiltration, and effector abundance remain downstream. If any one closes, upstream gain never reaches the tissue.

#### This is not a patient digital twin

**Typical misconception** Real assay values entered into the sliders would predict one patient’s response.

**Better mental model** The lab compresses complex processes into a few dimensionless parameters to expose causality and bottlenecks. It is not trained or calibrated to clinical outcomes and cannot guide diagnosis, dose, or treatment.

### Run the experiment

1. 01

   #### Create immune escape

   Choose Immune escape and identify which of the three worlds dims first.

   **What to observe:** Low antigen and weak binding reduce molecular occupancy first; cell signaling and organoid clearance shut down downstream.

2. 02

   #### Repair only the molecule

   Choose Receptor redesign, then gradually raise the checkpoint brake.

   **What to observe:** Binding on the left stays bright, but the center cell decision suddenly switches off at its threshold and tissue clearance disappears with it.

3. 03

   #### Open the complete cascade

   Choose Checkpoint rescue, then lower the effector ratio.

   **What to observe:** Molecular and cellular gates remain open, but the bottleneck moves to tissue access. Restoring the effector ratio makes the organoid collapse.

Physical conclusion

Molecule → cell → organ describes causal propagation: $\theta$ sets the input, $A$ sets cell state, and $C(t)$ becomes the tissue outcome. Engineering succeeds only when all three gates open.

Fields & matter · Starter path

## From a field to an electron microscope

Read a field, steer a charge, give an electron a wavelength, then use it to see a crystal and a surface.

[Start here → **Make an Electric Field Visible** Move the probe around a dipole and check that the field always points downhill on the potential landscape. Observe · 8 min](https://sandboxphysics.com/labs/electric-field/)

1. [1 Make an Electric Field Visible](https://sandboxphysics.com/labs/electric-field/)
2. [2 A Charge Bending through Fields](https://sandboxphysics.com/labs/charged-particle/)
3. [3 Electron Wavelength & Voltage](https://sandboxphysics.com/labs/electron-wavelength/)
4. [4 Electron Diffraction & Reciprocal Space](https://sandboxphysics.com/labs/electron-diffraction/)
5. [5 TEM Bright Field, Dark Field & SAED](https://sandboxphysics.com/labs/tem-mode-selector/)
6. [6 SEM Secondary-Electron Topography](https://sandboxphysics.com/labs/sem-topography/)

[View the full path →](https://sandboxphysics.com/topics/fields-and-matter/#starter-path)